Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
OMIM | RCV000018086 | SCV000038365 | drug response | Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in, somatic | 2004-05-20 | no assertion criteria provided | literature only | |
Laboratory for Molecular Medicine, |
RCV000038380 | SCV000062052 | pathogenic | Non-small cell lung carcinoma | 2009-11-23 | no assertion criteria provided | clinical testing | |
Database of Curated Mutations |
RCV000038380 | SCV000504231 | pathogenic | Non-small cell lung carcinoma | 2015-07-14 | no assertion criteria provided | literature only | |
Database of Curated Mutations |
RCV000426731 | SCV000504232 | likely pathogenic | Glioblastoma | 2016-05-31 | no assertion criteria provided | literature only | |
Database of Curated Mutations |
RCV000433465 | SCV000504233 | likely pathogenic | Lung adenocarcinoma | 2016-05-31 | no assertion criteria provided | literature only |